Response to Comment on Itoh et al. Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study. Diabetes Care 2018;41:1275

Response to Comment on Itoh et al. Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study. Diabetes Care 2018;41:1275–1284

Published:2018-10-15 Issue:11 Volume:41 Page:e145-e146
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Itoh Hiroshi¹^ORCID,Ueshima Kenji²,Komuro Issei³

Affiliation:

1. Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo, Japan

2. Department of EBM Research, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan

3. Department of Cardiovascular Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/41/11/e145/526931/dci180028.pdf

Reference7 articles.

1. Comment on Itoh et al. Intensive treat-to-target statin therapy in high-risk Japanese patients with hypercholesterolemia and diabetic retinopathy: report of a randomized study;Donzelli;Diabetes Care,2018

2. Intensive treat-to-target statin therapy in high-risk Japanese patients with hypercholesterolemia and diabetic retinopathy: report of a randomized study;Itoh;Diabetes Care,2018

3. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials;McKinney;Stroke,2012

4. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia;Matsuzaki;Circ J,2002

5. What cause of mortality can we predict by cholesterol screening in the Japanese general population?;Okamura;J Intern Med,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease;Circulation Journal;2024-04-25

2. 動脈硬化性疾患予防ガイドライン　2022 年版;Journal of Nihon University Medical Association;2023-04-01

3. V. The Risk Management in Secondary Prevention for Atherosclerotic Cardiovascular Disease;Nihon Naika Gakkai Zasshi;2023-02-10

4. IV. Management of Dyslipidemia in Diabetic Patients;Nihon Naika Gakkai Zasshi;2023-02-10

5. Dysregulated Serum Lipid Metabolism Promotes the Occurrence and Development of Diabetic Retinopathy Associated With Upregulated Circulating Levels of VEGF-A, VEGF-D, and PlGF;Frontiers in Medicine;2021-11-22